Arkadios Wealth Advisors Novavax Inc Transaction History

Arkadios Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$36.28 - $75.29 $1.73 Million - $3.59 Million	-47,630 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$69.73 - $142.9 $3.21 Million - $6.59 Million	46,089 Added 2990.85%	47,630 $3.51 Million
Q4 2021 Feb 03, 2022	SELL	$134.56 - $217.97 $14,801 - $23,976	-110 Reduced 6.66%	1,541 $220,000
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $168,198 - $255,968	946 Added 134.18%	1,651 $342,000
Q2 2021 Jul 28, 2021	SELL	$121.0 - $257.67 $214,170 - $456,075	-1,770 Reduced 71.52%	705 $149,000
Q1 2021 Apr 26, 2021	BUY	$112.98 - $319.93 $211,837 - $599,868	1,875 Added 312.5%	2,475 $448,000
Q4 2020 Feb 09, 2021	BUY	$78.74 - $139.5 $7,873 - $13,950	100 Added 20.0%	600 $66,000
Q2 2020 Aug 10, 2020	SELL	$13.86 - $83.61 $6,930 - $41,805	-500 Reduced 50.0%	500 $55 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $3,930 - $16,000	1,000 New	1,000 $13.6 Million

289

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $729M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.